13F filing recap · Q3 2009

What did Fairholme Capital Management buy in Q3 2009?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every Fairholme account, including accounts that belong to no fund below.

Stock value

$8.06B

Positions

Estimated turnover

33.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

WYEWyeth$203.45Mreported value+4.19M shares CAHCardinal Health, Inc.$40.92Mreported value+1.53M shares

Increased positions

SHLDQSears Holdings Corporation$997.74Mreported value+1.70M shares+12.5%JOEThe St. Joe Company$745.81Mreported value+860.2K shares+3.5%BRK.BBerkshire Hathaway Inc$575.31Mreported value+147.4K shares+573.5%HUMHumana Inc$558.11Mreported value+5.43M shares

Reduced positions

PFEPfizer Inc.$1.22Breported value-13.71M shares-15.7%HTZHertz Global Holdings Inc$634.97Mreported value-186.8K shares-0.3%FRXForest Laboratories Inc$439.11Mreported value-3.23M shares-17.8%WLPWellpoint Inc$314.68Mreported value-2.07M shares

Exited positions

UNHUnitedHealth Group Incorporated$247.67Mprior reported value-9.91M shares-100.0%BAThe Boeing Company$236.08Mprior reported value-5.55M shares-100.0%AXPAmerican Express Co$147.14Mprior reported value-6.33M shares-100.0%GDGeneral Dynamics Corp$115.76Mprior reported value-2.09M shares